Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?
Lee
Mary M
MM
D000293:Adolescent; D001827:Body Height / Q000187:drug effects*; D015519:Bone Density / Q000187:drug effects; D002648:Child; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology; D006130:Growth Disorders / Q000188:drug therapy*; D006801:Humans; D011627:Puberty / Q000187:drug effects; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; C066438:deslorelin